Letter: Effects of Rebamipide on Gastrointestinal Symptoms in Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2016;40:240-7)

Affiliations

Comment

Jin Hwa Kim. Diabetes Metab J. 2016 Aug.

. 2016 Aug;40(4):334-5.

doi: 10.4093/dmj.2016.40.4.334.

¹ Department of Endocrinology and Metabolism, Chosun University Hospital, Chosun University School of Medicine, Gwangju, Korea. endocrine@chosun.ac.kr.

No abstract available

Conflict of interest statement

No potential conflict of interest relevant to this article was reported.

Response: Effects of Rebamipide on Gastrointestinal Symptoms in Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2016;40:240-7).
Park S, Park SY, Rhee SY. Park S, et al. Diabetes Metab J. 2016 Aug;40(4):336-7. doi: 10.4093/dmj.2016.40.4.336. Diabetes Metab J. 2016. PMID: 27550211 Free PMC article. No abstract available.

Effects of Rebamipide on Gastrointestinal Symptoms in Patients with Type 2 Diabetes Mellitus.
Park S, Park SY, Kim YJ, Hong SM, Chon S, Oh S, Woo JT, Kim SW, Kim YS, Rhee SY. Park S, et al. Diabetes Metab J. 2016 Jun;40(3):240-7. doi: 10.4093/dmj.2016.40.3.240. Epub 2016 Apr 21. Diabetes Metab J. 2016. PMID: 27098506 Free PMC article.

1. Bytzer P, Talley NJ, Leemon M, Young LJ, Jones MP, Horowitz M. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch Intern Med. 2001;161:1989–1996. - PubMed
1. Verne GN, Sninsky CA. Diabetes and the gastrointestinal tract. Gastroenterol Clin North Am. 1998;27:861–874. vi–vii. - PubMed
1. Pasricha PJ, Pehlivanov N, Sugumar A, Jankovic J. Drug Insight: from disturbed motility to disordered movement: a review of the clinical benefits and medicolegal risks of metoclopramide. Nat Clin Pract Gastroenterol Hepatol. 2006;3:138–148. - PubMed
1. Kenney C, Hunter C, Davidson A, Jankovic J. Metoclopramide, an increasingly recognized cause of tardive dyskinesia. J Clin Pharmacol. 2008;48:379–384. - PubMed
1. McCallum RW, Ricci DA, Rakatansky H, Behar J, Rhodes JB, Salen G, Deren J, Ippoliti A, Olsen HW, Falchuk K, Hersh T. A multicenter placebo-controlled clinical trial of oral metoclopramide in diabetic gastroparesis. Diabetes Care. 1983;6:463–467. - PubMed